STAT5A and mature T-cell and NK-cell non-Hodgkin lymphoma: Our data support a role for STAT5 inhibition in PTCL and implicate potential utility for inhibition of STAT5 and activation of the extrinsic apoptotic pathway as combination therapy in PTCL.